PD-L1 (CD274) promoter hypomethylation predicts immunotherapy response in metastatic urothelial carcinoma
Volume 12, Issue 1, December 2023 .
Source: OncoImmunology - Category: Cancer & Oncology Authors: Niklas Kl ümperLennert WüstJonas SaalDamian J. RalserRomina ZarblJonas JarczykJohannes BreyerDanijel SikicBernd WullichChristian BolenzFlorian RoghmannMichael HölzelManuel RitterSebastian StriethArndt HartmannPhilipp ErbenRalph M. WirtzJennifer Landsbe Source Type: research